Method choice is crucial to when seeking answers to biosimilar characterization questions.
Guillaume Tremintin
Advertisement
Guillaume Tremintin is the biopharma market manager for Bruker Daltonics.
Articles by Guillaume Tremintin
Advertisement
Latest Updated Articles
Matching Tools to Biophysical Analysis DemandsJuly 1st 2017
Advertisement
Advertisement
Trending on BioPharm International
1
Zylidac Bio to Scale Prolific's Optogenetic Cell Line Platform to GMP
2
Sanofi Begins Construction of EU-Backed Insulin Plant in Frankfurt
3
BioNTech, BMS to Pair Pumitamig With Trodelvy in Phase 3 First-Line TNBC Trial
4
TaiMed’s Anti-CD4 Antibody TMB-365 Reduces HIV Viral Load in Phase 1, Supporting Long-Acting Combination Regimens
5